AdvisorShares Investments LLC Sells 8,352 Shares of Henry Schein, Inc. $HSIC

AdvisorShares Investments LLC lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 8.8% during the 1st quarter, Holdings Channel.com reports. The firm owned 86,345 shares of the company’s stock after selling 8,352 shares during the period. Henry Schein accounts for 1.2% of AdvisorShares Investments LLC’s investment portfolio, making the stock its 21st largest holding. AdvisorShares Investments LLC’s holdings in Henry Schein were worth $6,364,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Ameriprise Financial Inc. increased its stake in shares of Henry Schein by 3,275.2% in the second quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company’s stock worth $165,594,000 after purchasing an additional 2,199,695 shares in the last quarter. Bank of Montreal Can lifted its stake in shares of Henry Schein by 3,655.7% during the 4th quarter. Bank of Montreal Can now owns 2,144,773 shares of the company’s stock valued at $162,102,000 after buying an additional 2,087,666 shares in the last quarter. Norges Bank purchased a new position in shares of Henry Schein during the 4th quarter valued at $88,116,000. Southpoint Capital Advisors LP boosted its holdings in Henry Schein by 38.9% in the 4th quarter. Southpoint Capital Advisors LP now owns 2,500,000 shares of the company’s stock worth $188,950,000 after buying an additional 700,000 shares during the period. Finally, Bank of America Corp DE boosted its holdings in Henry Schein by 204.2% in the 2nd quarter. Bank of America Corp DE now owns 995,375 shares of the company’s stock worth $72,712,000 after buying an additional 668,182 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Director William K. Daniel purchased 10,000 shares of Henry Schein stock in a transaction that occurred on Monday, May 11th. The shares were bought at an average price of $69.19 per share, for a total transaction of $691,900.00. Following the completion of the transaction, the director owned 20,000 shares of the company’s stock, valued at approximately $1,383,800. This trade represents a 100.00% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.89% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on HSIC. Robert W. Baird set a $97.00 price target on Henry Schein in a report on Wednesday, May 6th. UBS Group reaffirmed a “neutral” rating and issued a $85.00 price objective (down from $87.00) on shares of Henry Schein in a research note on Wednesday, May 6th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Henry Schein in a research report on Monday, May 4th. Morgan Stanley reissued an “underweight” rating and set a $64.00 target price (up from $61.00) on shares of Henry Schein in a research note on Friday, April 24th. Finally, Citigroup initiated coverage on Henry Schein in a report on Wednesday, April 15th. They issued a “buy” rating and a $100.00 price target on the stock. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $87.85.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $86.43 on Friday. The firm has a market cap of $9.85 billion, a PE ratio of 26.11, a PEG ratio of 1.67 and a beta of 0.81. The stock has a 50 day moving average of $77.20 and a 200 day moving average of $77.07. The company has a current ratio of 1.36, a quick ratio of 0.75 and a debt-to-equity ratio of 0.59. Henry Schein, Inc. has a 12 month low of $61.94 and a 12 month high of $89.29.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.20 by $0.12. The business had revenue of $3.37 billion for the quarter, compared to the consensus estimate of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The company’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, research analysts expect that Henry Schein, Inc. will post 5.32 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.